Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,489 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel.
Ianiro G, Mullish BH, Kelly CR, Sokol H, Kassam Z, Ng SC, Fischer M, Allegretti JR, Masucci L, Zhang F, Keller J, Sanguinetti M, Costello SP, Tilg H, Gasbarrini A, Cammarota G. Ianiro G, et al. Among authors: keller j. Lancet Gastroenterol Hepatol. 2020 May;5(5):430-432. doi: 10.1016/S2468-1253(20)30082-0. Epub 2020 Mar 17. Lancet Gastroenterol Hepatol. 2020. PMID: 32192627 Free PMC article. No abstract available.
Faecal microbiota transplantation in clinical practice.
Terveer EM, van Beurden YH, Goorhuis A, Mulder CJJ, Kuijper EJ, Keller JJ; Working Group of The Netherlands Donor Feces Bank. Terveer EM, et al. Among authors: keller jj. Gut. 2018 Jan;67(1):196. doi: 10.1136/gutjnl-2017-313909. Epub 2017 Mar 8. Gut. 2018. PMID: 28274998 No abstract available.
Periodic screening of donor faeces with a quarantine period to prevent transmission of multidrug-resistant organisms during faecal microbiota transplantation: a retrospective cohort study.
Vendrik KEW, Terveer EM, Kuijper EJ, Nooij S, Boeije-Koppenol E, Sanders IMJG, van Lingen E, Verspaget HW, Berssenbrugge EKL, Keller JJ, van Prehn J; Netherlands Donor Faeces Bank Study Group. Vendrik KEW, et al. Among authors: keller jj. Lancet Infect Dis. 2021 May;21(5):711-721. doi: 10.1016/S1473-3099(20)30473-4. Epub 2020 Dec 1. Lancet Infect Dis. 2021. PMID: 33275940
SARS-CoV-2 vaccines and donor recruitment for FMT.
Ianiro G, Mullish BH, Hvas CL, Segal JP, Kuijper EJ, Costello SP, Kelly CR, Allegretti JR, Fischer M, Iqbal TH, Satokari R, Kao D, van Prehn J, Ng SC, Bibbò S, Baunwall SMD, Quraishi MN, Sokol H, Zhang F, Keller J, Masucci L, Quaranta G, Kassam Z, Sanguinetti M, Tilg H, Gasbarrini A, Cammarota G. Ianiro G, et al. Among authors: keller j. Lancet Gastroenterol Hepatol. 2021 Apr;6(4):264-266. doi: 10.1016/S2468-1253(21)00032-7. Epub 2021 Feb 8. Lancet Gastroenterol Hepatol. 2021. PMID: 33571456 Free PMC article. No abstract available.
Romanian National Guideline on Translating Fecal Microbiota Transplantation Applications related to Clostridioides difficile Infections into the Local Clinical Practice.
Gilca-Blanariu GE, Stefanescu G, Girleanu I, Iqbal T, Segal J, Mullish B, Quraishi MN, Keller J, Molnar T, Megraud F, Dumitrascu D, Manuc M, Iancu LS, Marica C, Gheorghe C, Manzoor S, Trifan A. Gilca-Blanariu GE, et al. Among authors: keller j. J Gastrointestin Liver Dis. 2021 Mar 13;30(1):147-163. doi: 10.15403/jgld-3297. J Gastrointestin Liver Dis. 2021. PMID: 33723543 Free article.
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.
Mullish BH, Merrick B, Quraishi MN, Bak A, Green CA, Moore DJ, Porter RJ, Elumogo NT, Segal JP, Sharma N, Marsh B, Kontkowski G, Manzoor SE, Hart AL, Settle C, Keller JJ, Hawkey P, Iqbal TH, Goldenberg SD, Williams HRT. Mullish BH, et al. Among authors: keller jj. Gut. 2024 Jun 6;73(7):1052-1075. doi: 10.1136/gutjnl-2023-331550. Gut. 2024. PMID: 38609165
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.
Mullish BH, Merrick B, Quraishi MN, Bak A, Green CA, Moore DJ, Porter RJ, Elumogo NT, Segal JP, Sharma N, Marsh B, Kontkowski G, Manzoor SE, Hart AL, Settle C, Keller JJ, Hawkey P, Iqbal TH, Goldenberg SD, Williams HRT. Mullish BH, et al. Among authors: keller jj. J Hosp Infect. 2024 Jun;148:189-219. doi: 10.1016/j.jhin.2024.03.001. Epub 2024 Apr 11. J Hosp Infect. 2024. PMID: 38609760
Human Transmission of Blastocystis by Fecal Microbiota Transplantation Without Development of Gastrointestinal Symptoms in Recipients.
Terveer EM, van Gool T, Ooijevaar RE, Sanders IMJG, Boeije-Koppenol E, Keller JJ, Bart A, Kuijper EJ; Netherlands Donor Feces Bank (NDFB) Study Group. Terveer EM, et al. Among authors: keller jj. Clin Infect Dis. 2020 Dec 17;71(10):2630-2636. doi: 10.1093/cid/ciz1122. Clin Infect Dis. 2020. PMID: 31728525 Free PMC article.
3,489 results